Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ocular Therapeutix Inc (NASDAQ:OCUL)

6.37
Delayed Data
As of Aug 26
 0.00 / 0.00%
Today’s Change
4.04
Today|||52-Week Range
20.47
-32.02%
Year-to-Date
No recent news for Ocular Therapeutix Inc.

Today’s Trading

Previous close6.37
Today’s open6.32
Day’s range6.16 - 6.47
Volume506,022
Average volume (3 months)787,245
Market cap$158.1M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+36.43%
Earnings growth (this year)-11.11%
Earnings growth (next 5 years)+43.00%
Revenue growth (last year)+126.68%
P/E ratioNM
Price/Sales124.46
Price/Book1.76

Competitors

 Today’s
change
Today’s
% change
NBRVNabriva Therapeutics...+0.02+0.27%
INNLInnocoll Holdings PL...-0.08-1.48%
STMLStemline Therapeutic...+0.24+2.93%
ATHXAthersys Inc-0.04-2.04%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$1.8M
Annual profit (last year)-$39.7M
Net profit margin-2,271.31%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Amarpreet S. Sawhney
Chief Operating Officer
James Fortune
Corporate headquarters
Bedford, Massachusetts

Forecasts

Partner Offers

Search for Jobs